Who Qualifies for Genomic Research Grants in Ohio
GrantID: 68425
Grant Funding Amount Low: Open
Deadline: Ongoing
Grant Amount High: Open
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Health & Medical grants, Non-Profit Support Services grants, Other grants, Science, Technology Research & Development grants.
Grant Overview
Ohio's Healthcare Challenges for Sickle Cell Disease
In Ohio, sickle cell disease (SCD) presents a unique healthcare challenge, particularly impacting African American communities. The Ohio Department of Health reports that SCD affects approximately 1 in every 365 African American births. However, despite these statistics, access to effective treatments and ongoing research efforts in genomic medicine remains limited, leading to inadequate care for individuals suffering from this debilitating condition.
Who Faces This Barrier Locally
The primary stakeholders facing challenges related to sickle cell disease in Ohio include patients, healthcare providers, and academic institutions engaged in research. Urban areas like Cleveland and Columbus highlight significant health disparities, with many SCD patients lacking access to specialized care and innovative treatment options. The burden of disease disproportionately affects individuals in economically disadvantaged areas, where healthcare resources are already stretched thin.
How Funding Addresses It
The funding initiative focuses on promoting genomic-based treatment research for sickle cell disease in Ohio. By supporting collaborations between local health systems, universities, and research organizations, the program aims to enhance the development of personalized treatments tailored specifically to the genetic profiles of patients. This funding is essential for driving forward cutting-edge research that can lead to breakthroughs in managing and treating SCD, ultimately improving patient outcomes.
Furthermore, this support also includes provisions for training healthcare providers on the nuances of genomic medicine as it pertains to sickle cell disease. As a result, local practitioners will be better equipped to implement advanced treatment strategies in their practice, fostering a more informed approach to patient care.
Who Should Apply in Ohio
Qualified recipients for this funding are tax-exempt nonprofit organizations recognized under Section 501(c)(3) of the Internal Revenue Code. Research institutions and healthcare organizations with a demonstrated track record of addressing sickle cell disease through innovative research or community outreach initiatives are ideal candidates. Applications that emphasize collaboration among various stakeholders in the healthcare ecosystem will have a stronger chance of approval.
Application Requirements and Realities
Interested organizations must submit a detailed proposal outlining their research objectives, timelines, and expected outcomes. This proposal should include partnerships with local healthcare systems and evidence of previous work in related areas to highlight their capacity to execute the planned initiative effectively. Notably, applicants must also address how their proposed research and training programs will directly contribute to improved management of sickle cell disease within Ohio's communities.
Fit Assessment for State Context
Given the state's health priorities, particularly within marginalized communities disproportionately affected by sickle cell disease, applications must align with Ohio’s public health directives. Projects that demonstrate a direct link between genomic research and improved healthcare access or outcomes for SCD patients will be prioritized. As such, applicants should clearly outline their strategies for integrating research findings into practical healthcare applications that truly benefit affected populations.
Conclusion
With the ongoing challenge of sickle cell disease in Ohio, this funding opportunity serves as a critical resource for advancing genomic research and treatment options. By connecting key stakeholders and facilitating innovative approaches to care, this initiative holds the potential to significantly enhance the lives of individuals living with sickle cell disease while also addressing broader health disparities in the state.
Eligible Regions
Interests
Eligible Requirements
Related Searches
Related Grants
Grant Nurturing the Next Generation of Bioeconomy Professionals in the U.S.
Through this grant, students could participate in educational competitions, projects, or initiatives...
TGP Grant ID:
59752
Grants for Enhancing Mental Health Care, Knowledge and Literacy
Grants to organizations focusing on improving mental health care for individuals and families by off...
TGP Grant ID:
67537
National Mass Violence Victimization Resource Center
The provider will grant to maintain the Center to identify and develop evidence-based best practices...
TGP Grant ID:
3841
Grant Nurturing the Next Generation of Bioeconomy Professionals in the U.S.
Deadline :
2023-12-14
Funding Amount:
$0
Through this grant, students could participate in educational competitions, projects, or initiatives that encourage them to think critically, solve re...
TGP Grant ID:
59752
Grants for Enhancing Mental Health Care, Knowledge and Literacy
Deadline :
Ongoing
Funding Amount:
Open
Grants to organizations focusing on improving mental health care for individuals and families by offering involvement, stabilization, and resilience,...
TGP Grant ID:
67537
National Mass Violence Victimization Resource Center
Deadline :
2023-04-25
Funding Amount:
$0
The provider will grant to maintain the Center to identify and develop evidence-based best practices that address the comprehensive needs of these vic...
TGP Grant ID:
3841